DEUTSCHE BANK AG\

Bank

Position in PRLD — Prelude Therapeutics Inc

CIK 948046 FRANKFURT AM MAIN, 2M

Position in PRLD

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$148,301

+$86,306 QoQ

Shares Held

27,824

-65.5% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 75 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 2% Shared 0% None 98%

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. PRLD ranks #262 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,579,110	$784,391,303
2	REGN	Regeneron Pharmaceuticals, Inc.	518,409	$323,248,743
3	ALNY	Alnylam Pharmaceuticals, Inc.	815,400	$245,459,858
4	RVMD	Revolution Medicines, Inc.	888,019	$166,308,196
5	RPRX	Royalty Pharma plc	2,717,951	$152,395,510
6	INCY	Incyte Corp	1,262,988	$143,172,312
7	ARGX	Argenx SE	137,335	$127,415,291
8	LGND	Ligand Pharmaceuticals Inc	249,611	$78,899,539

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$148,301	27,824	-65.5%	Shares	Defined	2026-08-07
2025-03-31	$61,995	80,723	-34.8%	Shares	Defined	2025-05-09
2024-12-31	$157,970	123,899	+747.6%	Shares	Defined	2025-06-30
2024-09-30	$30,259	14,618	0.0%	Shares	Defined	2025-06-26
2024-06-30	$55,694	14,618	+3177.6%	Shares	Defined	2025-06-12
2023-09-30	$1,378	446	-92.8%	Shares	Defined	2023-11-24
2022-03-31	$42,690	6,187	-10.2%	Shares	Defined	2022-05-13
2021-12-31	$85,742	6,887	+5.4%	Shares	Defined	2022-02-16
2021-09-30	$204,281	6,537	-82.4%	Shares	Defined	2021-11-04
2021-06-30	$1,063,117	37,133	+1.5%	Shares	Defined	2021-08-11
2021-03-31	$1,585,270	36,586	+442.0%	Shares	Defined	2021-05-13
2020-12-31	$482,962	6,750	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.